C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/99 (2006.01) A01N 43/02 (2006.01) A01N 43/06 (2006.01) A01N 43/08 (2006.01) A01N 43/16 (2006.01) A01N 43/18 (2006.01) C07D 307/00 (2006.01) C07D 307/22 (2006.01) C07D 307/32 (2006.01) C07D 307/48 (2006.01) C07D 307/83 (2006.01) C07D 307/86 (2006.01) C07D 309/00 (2006.01) C07D 309/30 (2006.01) C07D 319/06 (2006.01) C07D 321/00 (2006.01) C07D 333/02 (2006.01) C07D 333/12 (2006.01) C07D 333/22 (2006.01) C07D 335/00 (2006.01) C07D 335/02 (2006.01) C07D 405/12 (2006.01) C07D 407/12 (2006.01) C07D 409/12 (
Patent
CA 2288868
The invention relates to 3-hydroxy- and 3-keto-cyclohetero-substituted leucine compounds that are inhibitors of cysteine proteases, particularly cathepsin K, and are useful in the treatment of diseases in which inhibition of bone loss is a factor. The 3-hydroxy- or 3-keto-moiety is bonded to a tetrahydrothiophene, tetrahydrothiopyran, tetrahydrofuran or tetrahydropyran ring.
Cette invention se rapporte à des composés de leucine à substitution 3-hydroxy-cyclohétéro et 3-céto-cyclohétéro, qui constituent des inhibiteurs des cystéine-protéases, en particulier la cathépsine K, et qui sont utiles dans le traitement des maladies pour lesquelles l'inhibition de la déperdition osseuse constitue un facteur. La fraction 3-hydroxy ou 3-céto est liée à un cycle tétrahydrothiophène, tétrahydrothiopyranne, tétrahydrofuranne ou tétrahydropyranne.
Fenwick Ashley Edward
Gribble Andrew D.
Marquis Robert W.
Veber Daniel Frank
Witherington Jason
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
Smithkline Beecham P.l.c.
LandOfFree
Protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1371371